Results 191 to 200 of about 65,815 (207)

Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV

Critical Reviews in Clinical Laboratory Sciences, 2003
Anne-Marie Lambeir, Ingrid De Meester
exaly  

Dipeptidyl peptidase-4 (DPP-4) inhibitors

British Journal of Cardiology, 2017
openaire   +1 more source

Dipeptidyl-Peptidase-4-Hemmer und Herzinsuffizienz

Der Kardiologe, 2014
I. Vardarli, C. Özcelik
openaire   +1 more source

Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis

Cell Metabolism, 2017
Erin E Mulvihill, Elodie M Varin, John R Ussher   +2 more
exaly  

Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors

Circulation, 2017
Michael A Nauck, Juris J Meier, Matthew A Cavender   +2 more
exaly  

Dipeptidyl peptidase‐4 inhibitors and cardiovascular safety

Medical Journal of Australia, 2014
openaire   +2 more sources

Characterization and inhibition of a cholecystokinin-inactivating serine peptidase

Nature, 1996
exaly  

Interactive Hemodynamic Effects of Dipeptidyl Peptidase-IV Inhibition and Angiotensin-Converting Enzyme Inhibition in Humans

Hypertension, 2010
Nancy J Brown
exaly  

Dipeptidyl peptidase-4 inhibitors: sensitivity markers

Biotechnology. Theory and practice, 2017
A.N. Iskakova, A.M. Aitkulova, N.S. Sikhayeva, A.A. Romanova, L. Maratkyzy, Zh. A. Akanov, E.V. Zholdybayeva   +6 more
openaire   +1 more source

Alogliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits

Journal of the American Heart Association, 2017
Ning Jiang, Xue Liang, Gary Tse
exaly